The Management of Co-Morbidities in Patients with Heart Failure – Angina and Coronary Disease

Ilaria Spoletini, Petar Seferovic


Co-morbidities are particularly relevant in the management of HF as they may confound HF diagnosis, worsen symptomatology, impact quality of life and aggravate the prognosis. According to the most recent European Society of Cardiology (ESC) guidelines, treatment of co- morbidities is an essential element of the comprehensive care of HF. Angina and coronary artery disease (CAD), in particular are common disorders associated with HF. The pharmacological and surgical management of angina according to the ESC guidelines is reviewed in this article.


Cardiology; Coronary artery disease; Heart failure; Angina; Guidelines

Full Text:

451 HTML


Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, et al.

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016 Aug;18(8):891-975. doi: 10.1002/ejhf.592.

Braunstein, J. B., G. F. Anderson, G. Gerstenblith, W. Weller, M. Niefeld, R. Herbert and A. W. Wu (2003). Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare beneficiaries with chronic heart failure. J Am Coll Cardiol 42(7): 1226–1233.

Jolicoeur, E. M., A. Dunning, S. Castelvecchio, R. Dabrowski, M. A. Waclawiw, M. C. Petrie, R. Stewart, P. S. Jhund, P. Desvigne- Nickens, J. A. Panza, R. O. Bonow, B. Sun, T. R. San, H. R. Al- Khalidi, J. L. Rouleau, E. J. Velazquez and J. G. Cleland (2015). Importance of angina in patients with coronary disease, heart failure, and left ventricular systolic dysfunction: insights from STICH. J Am Coll Cardiol 66(19): 2092–2100.

Flather, M. D., M. C. Shibata, A. J. Coats, D. J. Van Veldhuisen, A. Parkhomenko, J. Borbola, A. Cohen- Solal, D. Dumitrascu, R. Ferrari, P. Lechat, J. Soler- Soler, L. Tavazzi, L. Spinarova, J. Toman, M. Bohm, S. D. Anker, S. G. Thompson, P. A. Poole- Wilson and S. Investigators (2005). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 26(3): 215–225.

Fonarow, G. C., W. G. Stough, W. T. Abraham, N. M. Albert, M. Gheorghiade, B. H. Greenberg, C. M. O’Connor, J. L. Sun, C. W. Yancy, J. B. Young, O.- H. Investigators and Hospitals (2007). Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE- HF Registry. J Am Coll Cardiol 50(8): 768–777.

Ambrosio, G., M. D. Flather, M. Bohm, A. Cohen- Solal, A. Murrone, F. Mascagni, G. Spinucci, M. G. Conti, D. J. van Veldhuisen, L. Tavazzi and A. J. Coats (2011). beta- blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. Heart 97(3): 209–214.

Bohm, M., A. Link, D. Cai, M. S. Nieminen, G. S. Filippatos, R. Salem, A. Cohen Solal, B. Huang, R. J. Padley, M. Kivikko and A. Mebazaa (2011). Beneficial association of beta- blocker therapy on recovery from severe acute heart failure treatment: data from the Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support trial. Crit Care Med 39(5): 940–944.

Swedberg, K., M. Komajda, M. Bohm, J. S. Borer, I. Ford, A. Dubost- Brama, G. Lerebours, L. Tavazzi and S. Investigators (2010). Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo- controlled study. Lancet 376(9744): 875–885.

Rosano, G. M., C. Vitale, B. Sposato, G. Mercuro and M. Fini (2003). Trimetazidine improves left ventricular function in diabetic patients with coronary artery disease: a double- blind placebo- controlled study. Cardiovasc Diabetol 2: 16.

Vitale, C., M. Wajngaten, B. Sposato, O. Gebara, P. Rossini, M. Fini, M. Volterrani and G. M. Rosano (2004). Trimetazidine improves left ventricular function and quality of life in elderly patients with coronary artery disease. Eur Heart J 25(20): 1814–1821.

Marazzi, G., M. Wajngarten, C. Vitale, R. Patrizi, F. Pelliccia, O. Gebara, H. Pierri, J. A. Ramires, M. Volterrani, M. Fini and G. M. Rosano (2007). Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Int J Cardiol 120(1): 79–84.

Marazzi, G., O. Gebara, C. Vitale, G. Caminiti, M. Wajngarten, M. Volterrani, J. A. Ramires, G. Rosano and M. Fini (2009). Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy. Adv Ther 26(4): 455–461.

Gao, D., N. Ning, X. Niu, G. Hao and Z. Meng (2011). Trimetazidine: a meta- analysis of randomised controlled trials in heart failure. Heart 97(4): 278–286.

Vitale, C., I. Spoletini, W. Malorni, P. Perrone- Filardi, M. Volterrani and G. M. Rosano (2013). Efficacy of trimetazidine on functional capacity in symptomatic patients with stable exertional angina – the VASCO- angina study. Int J Cardiol 168(2): 1078–1081.

Packer, M., C. M. O’Connor, J. K. Ghali, M. L. Pressler, P. E. Carson, R. N. Belkin, A. B. Miller, G. W. Neuberg, D. Frid, J. H. Wertheimer, A. B. Cropp and D. L. DeMets (1996). Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group. N Engl J Med 335(15): 1107–1114.

(Iona Study Group 2002). Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial. Lancet 359(9314): 1269–1275.

Cohn, J. N., D. G. Archibald, S. Ziesche, J. A. Franciosa, W. E. Harston, F. E. Tristani, W. B. Dunkman, W. Jacobs, G. S. Francis, K. H. Flohr and et al. (1986). Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med 314(24): 1547–1552.

Cohn, J. N., G. Johnson, S. Ziesche, F. Cobb, G. Francis, F. Tristani, R. Smith, W. B. Dunkman, H. Loeb, M. Wong and et al. (1991). A comparison of enalapril with hydralazine- isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 325(5): 303–310.

Goldstein, R. E., S. J. Boccuzzi, D. Cruess and S. Nattel (1991). Diltiazem increases late- onset congestive heart failure in postinfarction patients with early reduction in ejection fraction. The Adverse Experience Committee; and the Multicenter Diltiazem Postinfarction Research Group. Circulation 83(1): 52–60.

Cohn, J. N., S. Ziesche, R. Smith, I. Anand, W. B. Dunkman, H. Loeb, G. Cintron, W. Boden, L. Baruch, P. Rochin and L. Loss (1997). Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V- HeFT III. Vasodilator- Heart Failure Trial (V- HeFT) Study Group. Circulation 96(3): 856–863.

Windecker, S., P. Kolh, F. Alfonso, J. P. Collet, J. Cremer, V. Falk, G. Filippatos, C. Hamm, S. J. Head, P. Juni, A. P. Kappetein, A. Kastrati, J. Knuuti, U. Landmesser, G. Laufer, F. J. Neumann, D. J. Richter, P. Schauerte, M. Sousa Uva, G. G. Stefanini, D. P. Taggart, L. Torracca, M. Valgimigli, W. Wijns and A. Witkowski (2015). 2014 ESC/EACTS guidelines on myocardial revascularization. EuroIntervention 10(9): 1024–1094.

Montalescot, G., U. Sechtem, S. Achenbach, F. et al. (2013). 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34(38): 2949–3003.

Velazquez, E. J., K. L. Lee, M. A. Deja, A. Jain, G. Sopko, A. Marchenko, I. S. Ali, G. Pohost, S. Gradinac, W. T. Abraham, M. Yii, D. Prabhakaran, H. Szwed, P. Ferrazzi, M. C. Petrie, C. M. O’Connor, P. Panchavinnin, L. She, R. O. Bonow, G. R. Rankin, R. H. Jones, J. L. Rouleau and S. Investigators (2011). Coronary- artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 364(17): 1607–1616.

Shewan L.G., Coats A.J.S., Henein M. Requirements for Ethical Publishing in Biomedical Journals. International Cardiovascular Forum Journal. 2015;2:2.


Copyright (c) 2017 The Authors

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.